Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4199131000168114 | Aprepitant (Apotex) (aprepitant 165 mg) capsule, 1 capsule (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4199141000168117 | Aprepitant (Apotex) 165 mg capsule, 1 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aprepitant (Apotex) 165 mg capsule, 1 | Is a | aprepitant 165 mg capsule, 1 | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule, 1 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule, 1 | has TPUU | Aprepitant (Apotex) 165 mg capsule | true | Inferred relationship | Some | 1 | |
| Aprepitant (Apotex) 165 mg capsule, 1 | has TP | Aprepitant (Apotex) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aprepitant (Apotex) 165 mg capsule, 1, blister pack | Is a | True | Aprepitant (Apotex) 165 mg capsule, 1 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR